CHRS

Coherus Oncology, Inc. Common Stock

$1.57 -1.26%

Recent alerts on CHRS

All signals →

SEC filing CHRS Reports 124.6M Votes for Proposals 1-3,5; 91.8M Votes for Proposal 4; $0 Broker Non‑Votes on Routine Items

News Coherus targets $15M quarterly LOQTORZI sales in 2026 while advancing midyear tagmokitug and casdozokitug readouts

News Coherus outlines $175M annualized LOQTORZI target by 2028 as commercial expansion accelerates

News Coherus BioSciences Q4 2025 Earnings Preview

News Coherus Oncology prices stock offering to raise $50.1M

Get push alerts for CHRS

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS